Leo Cancer Care

Leo Cancer Care is a trans-Atlantic medical technology company focused on innovative radiation therapy solutions for cancer treatment. Founded in 2014 and originating from the University of Sydney, the company leverages over 100 years of combined experience in radiation therapy. Its core innovation is an upright patient positioning system that enhances patient comfort and treatment precision, allowing patients to receive therapy in a natural, relaxed posture. The flagship product, the Marie system, integrates the upright positioning platform with CT imaging capabilities. This technology is designed to improve treatment workflows and reduce capital costs for proton therapy centers by approximately 50%. Leo Cancer Care is currently advancing through regulatory approval processes, including a 510(k) submission for the CT component. The company aims to make cancer treatment more accessible and cost-effective, serving cancer treatment centers and hospitals worldwide. With over $60 million raised in global investment, Leo Cancer Care is committed to expanding its team and product development to meet growing demand.

• Employees 120
• Founded 2014
• Annual Revenue $12500000
• Total Funding $67800000